Skip to main content
Premium Trial:

Request an Annual Quote

Modern Mobility Aids Buying POC MDx Firm Lumigene Technologies

NEW YORK (GenomeWeb News) – Modern Mobility Aids today announced the execution of a definitive agreement to buy all of the common stock of point-of-care diagnostics shop Lumigene Technologies for an undisclosed amount.

Based in Mississauga, Ontario, LumiGene develops products for the diagnosis of infectious diseases. In a statement, Modern Mobility said that LumiGen's PosiCheck System, which is based on isothermal amplification technology, for the near sample/point-of-care DNA diagnostic markets "reliably and economically" automates DNA preparation and amplification for disease and pathogen detection in 30 minutes to one hour.

"LumiGene expects to be the first to market with a greatly needed new technology that we expect will be in high demand," Mohamed Karatella, president and CEO of Modern Mobility, said in a statement.

In September, LumiGene announced a reverse acquisition to be purchased by dance studio Pole Perfect Studios in a deal that would have taken LumiGene public. The deal was never completed, however.

Modern Mobility is based in Schaumburg, Ill., and recently underwent a corporate restructuring to focus on the pharmaceutical and biotechnology space.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.